In contrast to the findings in fibroblasts from MKD patients, where both the activated RhoA and Rac1 levels increased upon simvastatin treatment, the treatment of THP-1 cells caused a decrease in the levels of activated RhoA, whereas the levels of activated Rac1 increased (57, 58). The gene discussed is RHOA; the disease is mevalonic aciduria.